Atlas Trials

Besponsa Post Marketing Surveillance Study

Clinical trial NCT04307134 · COMPLETED

Trial details

NCT number
NCT04307134
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Hematologic Malignancy
Start date
2020-07-09
Primary completion
2024-12-24
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.